NeuroCovid: researchers are tracking what COVID-19 may mean for our brains
By Jane Kuszmaul
With the long-term effects of COVID research still in its infancy, researchers at NYU have set up a novel way to study and spread information surrounding the neurological effects that COVID has had on many. The COVID 19 Neuro Databank/Biobank (The NeuroCOVID Project) will hold anonymous contributions of biological specimens and corresponding data from individuals who have suffered from neurological side effects of COVID.
This conglomeration of data will allow researchers to better understand the long-term neurological effects of COVID that persist after individuals have recovered from illness. According to Dr. Barbara Karp, a physician on the NeuroCOVID Project Steering Committee, side effects can, “include headaches, fatigue, cognitive difficulties, stroke, pain and sleep disorders, as well as some very rare complications of serious infections.”
These are significant and wide-ranging health issues, and the goals of the NeuroCOVID database appear ambitious. They aim to collaborate with clinicians across the nation to collect biological samples and neurological data. Not only that, clinicians and researchers will be able to request the use of samples and data in what looks to be a wide range of studies.
It is possible that if you, or someone you know, is experiencing neurological side effects of COVID, you might be able to contribute yourself to the NeuroCOVID Project through a participating physician or researcher. A profusion of research is set to come of the NeuroCOVID Project in the coming months and years. To keep track of this project as it develops, you can follow the details at NYU, via this link:
Additional information that helped shape this post can be found at:
